Linical Co., Ltd. (2183.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Linical Co., Ltd.
Address
Shin-Osaka Brick Building
Osaka, 532-0003
Japan
Phone
81 6 6150 2478
Website
Sector
Healthcare
Industry
Biotechnology
Employees
662
First IPO Date
October 27, 2008
Key Executives
| Name | Title | Pay | Year Born |
| Kazuhiro Hatano | President, Chief Executive Officer, Chief Strategy Officer, Chief Commercial Officer & Representative Director | 0 | 1965 |
| Satoru Toyota | Executive Officer & Head of Oncology Business Unit (HQ, Japan) | 0 | N/A |
| Shiori Yamaguchi | Executive Officer & CCO | 0 | 1975 |
| Tomoko Inomata | Executive Officer & Head of Primary Business Unit (HQ, Japan) | 0 | N/A |
| Akihiro Takahashi | Executive Officer & CFO | 0 | 1967 |
| Jun Kawai | Executive Officer, Chief Clinical Operation Officer & Chief Administrative Officer | 0 | 1968 |
| Tracy Goeken | Chief Medical Officer | 0 | N/A |
| Toshiaki Nagafuji | Executive Officer, Chief Technology Officer & Head of Innovative Drug Development Business Unit (HQ, Japan) | 0 | N/A |
| Tokuno Masayoshi | Executive Officer & Chief Information Officer | 0 | N/A |
| Keigo Tsujimoto | Executive Officer & Chief Project Officer | 0 | 1964 |
| Clareece West | President & Chief Commercial Officer of Americas & Europe | 0 | N/A |
| Masaya Miyazaki | Executive Officer, APAC-Chief Commercial Officer & Chief Asia Pacific Officer | 0 | 1971 |
Description
Linical Co., Ltd. specializes in offering a wide range of drug development services to pharmaceutical companies across the globe. The company primarily assists in the therapeutic areas of oncology and central nervous system disorders. Its offerings encompass strategic consulting, including comprehensive market analysis for emerging products, expert advice on regulatory affairs, and assistance with licensing agreements. Furthermore, Linical manages clinical research and development programs and provides outsourced medical affairs support. These comprehensive services cover both the operational and post-study phases. Operational aspects include project oversight, trial monitoring, quality assurance, vendor coordination, auditing, and administrative support for clinical studies. Post-study activities involve data management, biostatistical analysis, medical writing, pharmacovigilance (drug safety monitoring), and overall medical management. The company was established in 2005 and maintains its corporate headquarters in Osaka, Japan.
